This inventor holds 12 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ikeda, JP (1990 - 1991)
- Osaka, JP (1992 - 2007)
- Tokyo, JP (2008 - 2017)
Company Filing History:
Years Active: 1990-2017
Title: Fumiyuki Shirai: Innovator in Pharmaceutical Chemistry
Introduction
Fumiyuki Shirai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target autoimmune diseases. With a total of 12 patents to his name, Shirai's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Shirai's latest patents involves a nitrogen-containing bicyclic aromatic heterocyclic compound. This compound is based on a cathepsin S inhibitory effect, which provides an excellent agent for treating or preventing autoimmune diseases, allergic diseases, graft rejection of organs, bone marrow or tissue, and systemic lupus erythematosus. The invention highlights the compound's effectiveness in inhibiting cathepsin S, making it a promising candidate for therapeutic applications.
Career Highlights
Throughout his career, Fumiyuki Shirai has worked with notable companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.
Collaborations
Shirai has collaborated with esteemed colleagues such as Toshiyuki Chiba and Masayoshi Murata. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.
Conclusion
Fumiyuki Shirai's contributions to pharmaceutical chemistry, particularly through his innovative patents, demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in the field, showcasing the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile